MCOs Posting 2Q Earnings Saw Satisfactory Gains in MA

While second-quarter 2020 earnings calls centered largely on uncertainty related to the COVID-19 pandemic, insurers with a large Medicare Advantage presence expressed satisfaction in membership growth so far this year and confidence in their positioning for the 2021 Annual Election Period (AEP).

Reporting second quarter earnings on Aug. 5, Humana Inc. exceeded analysts’ expectations with adjusted earnings per share (EPS) of $12.56 and other metrics that it attributed to customers delaying care due to stay-at-home orders and pandemic-related concerns. That deferral of care was partially offset by costs related to COVID-19 testing and treatment in the quarter as well as the company’s pandemic relief efforts, explained Chief Financial Officer Brian Kane during an Aug. 5 call to discuss recent quarterly earnings.

© 2025 MMIT
Lauren Flynn Kelly

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Lauren has been covering health business issues since the early 2000s and specializes in in-depth reporting on Medicare Advantage, managed Medicaid and Medicare Part D. She also possesses a deep understanding of the complex world of pharmacy benefit management, having written AIS Health’s Radar on Drug Benefits from 2004 to 2005 and again from 2011 to 2016. In addition to her role as managing editor of Radar on Medicare Advantage, she oversees AIS Health’s publications and manages the health editorial staff. She graduated from Vassar College with a B.A. in English.

Related Posts

unitedhealthcare-headquarters
October 3

UnitedHealthcare, Humana Nab Half of $11.8B in 2024 Quality Bonus Payments

READ MORE
stock-chart
October 3

’25 Stars Info Spooks Humana Investors, Stokes Fears About Industry Decline

READ MORE
elderly-woman-looking-at-ipad
October 3

Minn. Blues Plan’s Value-Based Pact With Herself Health Focuses on Senior Women

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today